Contact and Plasmin Kinin-Forming Systems in the Blood

K Buluk; Maria Czokało; M Małofiejew

doi:10.1055/s-0038-1654265

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1970; 24(03/04): 548-558
DOI: 10.1055/s-0038-1654265

Originalarbeiten – Original Articles – Travaux Originaux

Schattauer GmbH

Contact and Plasmin Kinin-Forming Systems in the Blood^[*]

K Buluk

¹Department of General and Experimental Pathology Medical School, Białystoic, Poland (Head: Prof. dr K. Buluk)

,

Maria Czokało

¹Department of General and Experimental Pathology Medical School, Białystoic, Poland (Head: Prof. dr K. Buluk)

,

M Małofiejew

¹Department of General and Experimental Pathology Medical School, Białystoic, Poland (Head: Prof. dr K. Buluk)

› Author Affiliations

Abstract

Summary

By means of preparations of two different kininogens, the existence of two kallikreins, postulated previously, that is one activated by the contact factor – contact kallikrein, and another by plasmin – plasmin kallikrein, has been confirmed.

Stasis plasma or plasma from blood taken without stasis incubated at 37 ° C can be a source of contact kallikrein.

It was found that modified plasma, that is plasma acidified to pH 2 and realkalized after 10 min, is suitable material for demonstrating that plasmin activates plasmin kallikrein. Plasmin kallikrein in the plasma has two substrates: kininogen – from which it releases kinins, and contact kallikrein which it inactivates. A diagram showing the activation of kinin-forming systems in the blood plasma is proposed.

Full Text

References

References
1 Alkjaersig N, Fletcher A. P, Sherry S. The mechanism of clot dissolution by plasmin. J. clin. Invest 38: 1086 1959;
2 Armstrong D, Jepson J. B, Keele G. A, Stewart I. W. Activation by glass of pharmacologically active agents in blood of various species. J. Physiol. (Lond) 129: 80 1955;
3 Armstrong D, Mills G. L. Physiological influence on the liberation of human plasma kinin at low temperatures. In: Erdös E. G, Back N, Sicuteri F. Hypotensive peptides. 139 Springer; New York: 1966
4 Back N, Guth P. S, Munson A. E. On the relationship between plasmin and kinin. Ann. N.Y. Acad. Sci 104: 53 1963;
5 Back N, Steger R. Activation of bovine bradykininogen by human plasmin. Life Sci 04: 153 1965;
6 Back N. Fibrinolysin system and vasoactive kinins. Fed. Proc 25: 77 1966;
7 Beraldo W. T. Formation of bradykinin in anaphylactic and peptone shock. Amer. J. Physiol 163: 283 1950;
8 Bielawiec M. Clinical and experimental studies on fibrinolysis activation. Rocz-i Akad. Med. Bialyst. 1967. suppl. 15.
9 Bjüro T. Histamine metabolism in adrenalectomized rats. Acta physiol, scand 60: 220 1963;
10 Blümel G, Fischer M, Lechner K. Plasmakininogenspiegel und Proteinasenhemmkörper : Beobachtungen während der Substitutionstherapie bei Hämophilie A. Thrombos. Diathes. haemorrh. (Stuttg) 18: 364 1967;
11 Buluk K, Januszko T, Killar M, Olbromski J. Activator of plasminogen and streptoplasmin. Post. Hig. Med. Dosw 14: 559 1960;
12 Buluk K, Malofiejew M. Urokinase induced activation of kallikreinogen and the release of plasma kinins in renal blood. Acta. med. pol 06: 405 1965;
13 Buluk K, Malofiejew M. Kallikrein formation by plasmin and release of plasma kinin in human blood. Proc. 10th Congr. European Soc. Haemat., Strassbourg. 1260 1965
14 Buluk K, Malofiejew M, Czokalo M. Activation of fibrinolysis and of plasma-kinin system during venostasis. Thrombos. Diathes. haemorrh. (Stuttg.) 14: 500 1965;
15 Buluk K, Januszko T, Olbromski J. Further studies on obtaining and purifying of plasminogen. 8th Congr. Pol. Haemat. Soc. Lodz. 1966
16 Buluk K, Malofiejew M, Czokalo M. On the kinin-forming systems: activated by plasmin and activated by the contact factor. Pol. Tyg. Lek 22: 1140 1967;
17 Buluk K, Czokalo M, Malofiejew M, Januszko T. Generation of kallikreins in the blood plasma. Acta physiol, pol 19: 154 1968;
18 Buluk K, Czokalo M, Malofiejew M. The blood kinin-forming system activated by plasmin. (Added to press).
19 Geländer D. R, Guest M. M. Purification and properties of a urinary activator of plasma profibrinolysin. Fed. Proc 14: 26 1955;
20 Colman R. W, Matter L, Sherry S. Studies on the prekallikrein (kallikreinogen)-kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J. clin. Invest 48: 11 1969;
21 Czokalo M. Kininogenesis in plasma of human blood. Doctoral thesis..
22 Eisen V. Enzymic aspects of plasma kinin formation. Proc. Roy. Soc. B 173: 351 1969;
23 Eisen V, Keele C. A. Possible modes of kinin formation in some pathological states in man. Hypotensive Peptides. 551 Springer; Berlin, Heidelberg, New York: 1966
24 Frey E. K, Kraut H, Werle E. Kallikrein (Padutin). F. Enke; Stuttgart: 1950
25 Gaddum J. H, Horton E. W. The extraction of human urinary kinin (substance Z) and its relation to the plasma kinins. Brit. J. Pharmacol 14: 117 1959;
26 Garbe G, Vogt W. Zur Natur der im menschlichen Plasma durch Pankreaskallikrein, Glaskontakt und Säurebehandlung gebildeten Kinine. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak 256: 119 1967;
27 Hamberg U. Fibrinolytic activation and bradykinin release. Biochim. biophys. Acta (Amst) 36: 296 1959;
28 Hamberg U. Isolation of bradykinin from human plasma. Mode of release, amino acid composition and molar activity. Ann. Acad. Sci. fenn. Ser. A., Chemica 1 1962;
29 Hamberg U. Plasma protease and kinin release with special reference to plasmin. Ann. N.Y. Acad. Sci 146: 517 1968;
30 Hamberg U. Influences on the kinins system by proteolysis in human plasma. Proc. Roy. Soc. B 173: 393 1969;
31 Holemans R, McConnell D, Johnston J. G. Hageman Factor and fibrinolysis. Amer. J. med. Sci 251: 557 1966;
32 Horton E. W. The estimation of urinary kallikrein. J. Physiol. (Lond) 148: 267 1959;
33 latridis S. G, Ferguson J. H. Active Hageman factor: A plasma lysokinase of the human fibrinolytic system. J. clin. Invest 41: 1277 1962;
34 latridis S. G, latridis P. G, Ferguson J. H. The role of HF (Factor XII) in the pathogenesis of the thrombolytic state induced by venous occlusion. Thrombos. Diathes. haemorrh. (Stuttg) 16: 207 1966;
35 Januszko T, Dubinska L. Estimation of the activator of fibrinolysis by means of the euglobulin test. Acta med. pol 06: 269 1965;
36 Januszko T, Kleniewski J. Activation of contact factor in diluted plasma. Pol. Tver. Lek 20: 1612 1965;
37 Januszko T, Buluk K. Hageman factor as plasminogen plasma activator. Pol. Arch. med. Wewn 40: 197 1968;
38 John G, Vogt W. Kininbildung in frischem und glasaktiviertem menschlichem Plasma. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak 251: 186 1965;
39 Keele C. A. Formation of pain-producing polypeptide (PPS) from plasma. In: Schächter M. Polypeptides which affect smooth muscles and blood vessels. 253 Pergamon Press; 1960
40 Kleniewski J. The contact factor and fibrinolysis. Acta med. pol 06: 257 1965;
41 Lewis G. P, Work T. Formation of bradykinin or bradykinin like substances by the action of plasmin on plasma proteins. J. Physiol. (Lond) 135: 7 1956;
42 Lewis G. P. Formation of plasma kinins by plasmin. J. Physiol. (Lond) 140: 285 1958;
43 Lewis G. P. Active polipeptides derived from plasma proteins. Physiol. Rev 40: 647 1960;
44 Läufer A. L, Gulikova O. M, Paskhina T. S. Two kinin-prodncing enzymes from the blood plasma of man. Biochimija 34: 3 1969;
45 Lukjan H. Behaviour kinin-forming systems during activation of fibrinolysis in blood (Doctoral thesis).
46 Magnus R. Versuche am überlebenden Dünndarm von Säugetieren. I. Mitteilung. Arch. Physiol, norm. path 102: 123 1904;
47 Malofiejew M, Buluk K, Gzokalo M. A preparation of kininogen for the assay of kallikreins. Thrombos. Diathes. haemorrh. (Stuttg) 16: 723 1966;
48 Malofiejew M, Reutt H, Buluk K, Januszko T. Behaviour of plasminogen activator, kallikrein and plasma kinins during muscular exercise. Pol. Tyg. Lek 48: 1833 1966;
49 Malofiejew M. The function of blood polypeptides. Post. Hig. Med. Dosw 21: 465 1967;
50 Margolis J. Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J. Physiol. (Lond) 144: 1 1958;
51 Margolis J. The mode of action of Hageman factor in the release of plasma kinin. J. Physiol. (Lond) 151: 238 1960;
52 Margolis J. The interrelationship of coagulation of plasma and release of peptides. Ann. N.Y. Acad. Sci 104: 133 1963;
53 Margolis J. Quantitative studies of kinin-releasing enzymes in plasma. Erdös E, Back N, Sicuteri F. Hypotensive peptides. 198 Springer; New York: 1966
54 Niewiarowski S, Prou-Wartelle O. Role du facteur contact (facteur Hageman) dans la fibrinolyse. Thrombos. Diathes. haemorrh. (Stuttg) 03: 593 1959;
55 Ratnoff O. D, Miles A. A. The induction of permeability - increasing activity in human plasma by activated Hageman factor. Brit. J. exp. Path 45: 328 1964;
56 Rocha e Silva M, Beraldo W. T, Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Amer. J. Physiol 156: 261 1949;
57 Salmon J, Lecomte J. Rôle de la fibrinolyse dans le chock anaphylactique du lapin. Int. Arch. Allergy 22: 378 1963;
58 Schächter M. A delayed slow-contracting effect of serum and plasma due to the release of a substance resembling kallikrein and bradykinin. Brit. J. Pharmac 11: 111 1956;
59 Schächter M. Some properties of kallidin, bradykinin and wasp venom kinin. In: Schächter, M. Polypeptides which affect smooth muscles and blood vessels. 232 Pergamon Press; 1966
60 Soulier J. P, Prou-Wartelle O. Nouvells données sur les facteurs Hageman et P.T. A. et sur le « contact ». Rev. franç. Étud. clin. biol 04: 932 1959;
61 Verstraete M, Amery A, Vermylen J. The feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl 03: 211 1963;
62 Verstraete M, Amery A, Vermylen J. Enzymatic clot dissolution in man: a new therapeutic approach. Acta clin. belg 19: 271 1964;
63 Vogt W. Kinin formation by plasmin, and indirect process mediated by activation of kallikrein. J. Physiol. (Lond) 170: 153 1964;
64 Vogt W. Ein komplettes zweites kininbildendes System im menschlichen Plasma. Naunyn- Schmiedebergs Arch. exp. Path. Pharmac 251: 186 1965;
65 Vogt W. Demonstration of the presence of two separate kinin-forming systems in human and other plasma. In: Erdös E. G, Back N, Sicuteri F. Hypotensive Peptides. 185 Springer; New York: 1966
66 Webster M. E, Ratnoff O. D. Role of Hageman factor in the activation of vasodilator activity in human plasma. Nature 192: 180 1961;
67 Webster M, Innerfield I. Interrelationship of human plasma kallikrein and plasmin in inflammation. Enzymol. biol. clin 03: 129 1965;
68 Werle E. Über die Inactivierung des Kallikreins. Biochem. Z 273: 291 1934;

Contact and Plasmin Kinin-Forming Systems in the Blood[*]

Contact and Plasmin Kinin-Forming Systems in the Blood^[*]